Commercializing Living Therapies with CCRM
Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.
Podcasting since 2021 • 23 episodes
Commercializing Living Therapies with CCRM
Latest Episodes
Investing in the future of medicine: Trends, hurdles and opportunities in the CGT sector
Reni Benjamin, Managing Director, Healthcare Equity Research at CitizensBrock Reeve, CEO and Co-founder, Eos BioInnovation***In this episode of Commercializing Living Therapies with CCRM, host Krista Lamb speaks wi...
•
Season 4
•
Episode 5
•
38:18
Navigating commercialization: Regional hubs, global solutions
Featuring:Silvio Tiziani, CEO, CCRM AustraliaSarah Callens, CTO, CCRM Nordic***In this episode of Commercializing Living Therapies with CCRM, Silvio Tiziani, CEO, CCRM Australia, and Sarah Callens, CTO, CCRM...
•
Season 4
•
Episode 4
•
23:09
Enabling patient access to cell and gene therapies
Featuring:Durhane Wong-Rieger, PhD, President and CEO, Canadian Organization for Rare DisordersJacqueline Barry, PhD, Chief Clinical Officer, Cell and Gene Therapy Catapult***In this episode, we dive into the critica...
•
Season 4
•
Episode 3
•
28:20
Unapproved stem cell therapies: Risks, realities and responsibilities
Featuring:Paul Knoepfler, PhD, Professor of Cell Biology and Human Anatomy, UC Davis School of MedicineAmy Zarzeczny, PhD LLM, Associate Professor, Johnson Shoyama Graduate School of Public Policy, University of Regina***
•
Season 4
•
Episode 2
•
35:30
Biomanufacturing redefined: The role of AI and robotics in producing cell and gene therapies
Featuring:Christopher P. Boone, PhD, Group Vice President, Research Services, Health & Life Sciences, OracleKenneth L. Harris, Chief Strategy Officer and Head of AI, OmniaBio Inc. ***We are excited to sh...
•
Season 4
•
Episode 1
•
34:59
